News Sep 30, 2026
AI helps uncover molecular glues that could treat immune diseases
Researchers at Baylor College of Medicine have developed a computational workflow called GluePlex that uses artificial intelligence to accelerate the discovery of molecular glue drugs. These small molecules work by bringing target proteins to the cell's natural disposal system. The team identified compounds that selectively remove VAV1, a protein linked to blood cancers and autoimmune diseases, and demonstrated their effectiveness in human immune cells.
Giulio Prisco 2 min read